Bruce G. Allen Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Bruce G. Allen Investments's BMY Position: Q1 2026 in Review
Bruce G. Allen Investments increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $14.7K and bringing the position to 1,738 shares worth $105K. The position accounts for 0.07% of the portfolio, ranked #151.
Bruce G. Allen Investments first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $209K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Bruce G. Allen Investments held 1,738 shares of Bristol-Myers Squibb worth $105K as of Q1 2026.
- Bruce G. Allen Investments bought 253 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.7K.
- Bristol-Myers Squibb made up 0.07% of Bruce G. Allen Investments's portfolio in Q1 2026, its #151 holding.
- Bruce G. Allen Investments first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- Bruce G. Allen Investments's Bristol-Myers Squibb position peaked at $209K in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.